Researchers at Imperial College London have discovered a new way in which a very common childhood disease could be treated. In the first year of life, 65 per cent of babies get infected by Respiratory Syncytial Virus (RSV). ...
Feb 4, 2013
0
0
University of Hong Kong scientists claim to have the first evidence of someone being reinfected with the virus that causes COVID-19.
Aug 24, 2020
1
127
A KAIST immunology research team found that most convalescent patients of COVID-19 develop and maintain T cell memory for over 10 months regardless of the severity of their symptoms. In addition, memory T cells proliferate ...
Jul 5, 2021
0
170
A phase I/IIa clinical trial that the University of Oxford collaborated on has demonstrated that a T-cell therapeutic HIV vaccine was associated with better control of the virus rebound when antiretroviral therapy (ART) was ...
Nov 4, 2022
0
33
An experimental malaria vaccine protected healthy subjects from infection with a malaria strain different from that contained in the vaccine, according to a study published today in the Proceedings of the National Academy ...
Feb 20, 2017
0
61
A new study published in Nature Medicine from scientists at the Technion, Stanford and CytoReason describes for the first time ever a way to quantify a person's "immune age." This game-changing capability provides a much ...
Mar 12, 2019
0
169
The antibody response from an HIV vaccine trial in Thailand was made possible by a genetic trait carried over in humans from an ancient ancestry with monkeys and apes, according to a study led by Duke Medicine researchers.
Jan 16, 2015
1
12
In a scientific discovery that has significant implications for preventing HIV infections, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have identified a protein that could improve the body's ...
Jun 4, 2015
0
28
Researchers at The University of Texas Medical Branch at Galveston have developed less expensive way to produce vaccines that cuts the costs of vaccine production and storage by up to 80 percent without decreasing safety ...
Oct 5, 2018
0
48
Even though 11.4 million doses of the approved Pfizer and Moderna COVID-19 vaccines had been distributed across the United States by Monday morning, just 2.1 million had made it into the arms of high-risk Americans.
Jan 4, 2021
0
12
